Caveolin-1: A critical regulator of lung fibrosis in idiopathic pulmonary fibrosis

Journal of Experimental Medicine

Volumn 203, Issue 13, 2006, Pages 2895-2906

  Xiao, Mei Wang ^a   Zhang, Yingze ^a   Hong, Pyo Kim ^a   Zhou, Zhihong ^a   Feghali Bostwick, Carol A ^a   Liu, Fang ^a   Ifedigbo, Emeka ^a   Xu, Xiaohui ^b   Oury, Tim D ^a   Kaminski, Naftali ^a   Choi, Augustine M K ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CAVEOLIN 1; HYDROXYPROLINE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL ACTIVATION; CELL CULTURE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; LUNG FIBROBLAST; LUNG FIBROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ACTINS; ANIMALS; BLEOMYCIN; CAVEOLIN 1; COLLAGEN TYPE I; EPITHELIAL CELLS; EXTRACELLULAR MATRIX; FIBROBLASTS; FIBRONECTINS; FIBROSIS; GENE EXPRESSION; HUMANS; HYDROXYPROLINE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 8; PHOSPHORYLATION; PULMONARY FIBROSIS; RNA, SMALL INTERFERING; SMAD2 PROTEIN; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33845899411     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20061536     Document Type: Article

References (44)

1. Anderson, R.G. 1993. Caveolae: where incoming and outgoing messengers meet. Proc. Natl. Acad. Sci. USA. 90:10909-10913.
2. Scherer, P.E., R.Y. Lewis, D. Volonte, J.A. Engelman, F. Galbiati, J. Couet, D.S. Kohtz, E. van Donselaar, P. Peters, and M.P. Lisanti. 1997. Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J. Biol. Chem. 272:29337-29346.
3. Rothberg, K.G., J.E. Heuser, W.C. Donzell, Y.S. Ying, J.R. Glenney, and R.G. Anderson. 1992. Caveolin, a protein component of caveolae membrane coats. Cell. 68:673-682.
4. Tang, Z., P.E. Scherer, T. Okamoto, K. Song, C. Chu, D.S. Kohtz, I. Nishimoto, H.F. Lodish, and M.P. Lisanti. 1996. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J. Biol. Chem. 271:2255-2261.
5. Okamoto, T., A. Schlegel, P.E. Scherer, and M.P. Lisanti. 1998. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J. Biol. Chem. 273:5419-5422.
6. Mineo, C., G.L. James, E.J. Smart, and R.G. Anderson. 1996. Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane. J. Biol. Chem. 271:11930-11935.
7. Liu, P., Y. Ying, Y.G. Ko, and R.G. Anderson. 1996. Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae. J. Biol. Chem. 271:10299-10303.
8. Khalil, N., and R. O' Connor. 2004. Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatment. CMAJ. 171:153-160.
9. Brown, K.K., and G. Raghu. 2004. Medical treatment for pulmonary fibrosis: current trends, concepts, and prospects. Clin. Chest Med. 25:759-772.
10. American Thoracic Society. 2000. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am. J. Respir. Crit. Care Med. 161:646-664.
11. Selman, M., V.J. Thannickal, A. Pardo, D.A. Zisman, F.J. Martinez, and J.P. Lynch III. 2004. Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches. Drugs. 64:405-430.
12. Lasky, J.A., and A.R. Brody. 2000. Interstitial fibrosis and growth factors. Environ. Health Perspect. 108:751-762.
13. Tourkina, E., P. Gooz, J. Pannu, M. Bonner, D. Scholz, S. Hacker, R.M. Silver, M. Trojanowska, and S. Hoffman. 2005. Opposing effects of protein kinase Calpha and protein kinase Cepsilon on collagen expression by human lung fibroblasts are mediated via MEK/ERK and caveolin-1 signaling. J. Biol. Chem. 280:13879-13887.
14. Kasper, M., D. Seidel, L. Knels, N. Morishima, A. Neisser, S. Bramke, and R. Koslowski. 2004. Early signs of lung fibrosis after in vitro treatment of rat lung slices. Histochem. Cell Biol. 121:131-140.
15. Kasper, M., T. Reimann, U. Hempel, K.W. Wenzel, A. Bierhaus, D. Schuh, V. Dimmer, G. Haroske, and M. Muller. 1998. Loss of caveolin expression in type I pneumocytes as an indicator of subcellular alterations during lung fibrogenesis. Histochem. Cell Biol. 109:41-48.
16. Koslowski, R., K. Barth, A. Augstein, T. Tschernig, G. Bargsten, M. Aufderheide, and M. Kasper. 2004. A new rat type I-like alveolar epithelial cell line R3/1: bleomycin effects on caveolin expression. Histochem. Cell Biol. 121:509-519.
17. Schwartz, E.A., E. Reaven, J.N. Topper, and P.S. Tsao. 2005. Transforming growth factor-beta receptors localize to caveolae and regulate endothelial nitric oxide synthase in normal human endothelial cells. Biochem. J. 390:199-206.
18. Razani, B., X.L. Zhang, M. Bitzer, G. von Gersdorff, E.P. Bottinger, and M.P. Lisanti. 2001. Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor. J. Biol. Chem. 276:6727-6738.
19. Drab, M., P. Verkade, M. Elger, M. Kasper, M. Lohn, B. Lauterbach, J. Menne, C. Lindschau, F. Mende, F.C. Luft, et al. 2001. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 genedisrupted mice. Science. 293:2449-2452.
20. Pardo, A., K. Gibson, J. Cisneros, T.J. Richards, Y. Yang, C. Becerril, S. Yousem, I. Herrera, V. Ruiz, M. Selman, and N. Kaminski. 2005. Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PLoS Med. 2:e251.
21. Selman, M., A. Pardo, L. Barrera, A. Estrada, S.R. Watson, K. Wilson, N. Aziz, N. Kaminski, and A. Zlotnik. 2006. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am. J. Respir. Crit. Care Med. 173:188-198.
22. Allen, J.T., and M.A. Spiteri. 2002. Growth factors in idiopathic pulmonary fibrosis: relative roles. Respir. Res. 3:13.
23. Choi, M.E. 2000. Mechanism of transforming growth factor-beta1 signaling. Kidney Int. Suppl. 77:S53-S58.
24. Yue, J., and K.M. Mulder. 2000. Activation of the mitogen-activated protein kinase pathway by transforming growth factor-beta. Methods Mol. Biol. 142:125-131.
25. Fujita, Y., S. Maruyama, H. Kogo, S. Matsuo, and T. Fujimoto. 2004. Caveolin-1 in mesangial cells suppresses MAP kinase activation and cell proliferation induced by bFGF and PDGF. Kidney Int. 66:1794-1804.
26. Wang, X.M., H.P. Kim, R. Song, and A.M. Choi. 2006. Caveolin-1 confers antiinflammatory effects in murine macrophages via the MKK3/p38 MAPK pathway. Am. J. Respir. Cell Mol. Biol. 34:434-442.
27. Katzenstein, A.L., and J.L. Myers. 1998. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am. J. Respir. Crit. Care Med. 157:1301-1315.
28. Selman, M., and A. Pardo. 2002. Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder. Respir. Res. 3:3.
29. Yamamoto, Y., T. Kubota, Y. Atoji, and Y. Suzuki. 1996. Structure of the perilobular sheath of the deep proventricular gland of the chicken: presence and possible role of myofibroblasts. Cell Tissue Res. 285:109-117.
30. Aono, Y., Y. Nishioka, M. Inayama, M. Ugai, J. Kishi, H. Uehara, K. Izumi, and S. Sone. 2005. Am. J. Respir. Crit. Care Med. 171:1279-1285.
31. Schiller, M., D. Javelaud, and A. Mauviel. 2004. TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. J. Dermatol. Sci. 35:83-92.
32. Sime, P.J., Z. Xing, F.L. Graham, K.G. Csaky, and J. Gauldie. 1997. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J. Clin. Invest. 100:768-776.
33. Raghu, G., W.C. Johnson, D. Lockhart, and Y. Mageto. 1999. Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study. Am. J. Respir. Crit. Care Med. 159:1061-1069.
34. Atamas, S.P., I.G. Luzina, J. Choi, N. Tsymbalyuk, N.H. Carbonetti, I.S. Singh, M. Trojanowska, S.A. Jimenez, and B. White. 2003. Pulmonary and activation-regulated chemokine stimulates collagen production in lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 29:743-749.
35. Sato, M., D. Shegogue, A. Hatamochi, S. Yamazaki, and M. Trojanowska. 2004. Lysophosphatidic acid inhibits TGF-beta-mediated stimulation of type I collagen mRNA stability via an ERK-dependent pathway in dermal fibroblasts. Matrix Biol. 23:353-361.
36. Hocevar, B.A., T.L. Brown, and P.H. Howe. 1999. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J. 18:1345-1356.
37. American Thoracic Society. 2002. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am. J. Respir. Crit. Care Med. 165:277-304.
38. Kuan, C.Y., D.D. Yang, D.R. Samanta Roy, R.J. Davis, P. Rakic, and R.A. Flavell. 1999. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron. 22:667-676.
39. Fattman, C.L., L.Y. Chang, T.A. Termin, L. Petersen, J.J. Enghild, and T.D. Oury. 2003. Enhanced bleomycin-induced pulmonary damage in mice lacking extracellular superoxide dismutase. Free Radic. Biol. Med. 35:763-771.
40. Tan, R.J., C.L. Fattman, S.C. Watkins, and T.D. Oury. 2004. Redistribution of pulmonary EC-SOD after exposure to asbestos. J. Appl. Physiol. 97:2006-2013.
41. Zhou, Z., R. Song, C.L. Fattman, S. Greenhill, S. Alber, T.D. Oury, A.M. Choi, and D. Morse. 2005. Carbon monoxide suppresses bleomycin-induced lung fibrosis. Am. J. Pathol. 166:27-37.
42. Cho, K.A., S.J. Ryu, J.S. Park, I.S. Jang, J.S. Ahn, K.T. Kim, and S.C. Park. 2003. Senescent phenotype can be reversed by reduction of caveolin status. J. Biol. Chem. 278:27789-27795.
43. Kaminski, N., and N. Friedman. 2002. Practical approaches to analyzing results of microarray experiments. Am. J. Respir. Cell Mol. Biol. 27:125-132.
44. Godfrey, T.E., S.H. Kim, M. Chavira, D.W. Ruff, R.S. Warren, J.W. Gray, and R.H. Jensen. 2000. Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5' nuclease quantitative reverse transcription-polymerase chain reaction. J. Mol. Diagn. 2:84-91.